Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
about
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
description
clinical trial
@en
klinisch onderzoek
@nl
name
Veliparib, Capecitabine, and T ...... Recurrent Neuroendocrine Tumor
@en
Veliparib, Capecitabine, and T ...... Recurrent Neuroendocrine Tumor
@nl
type
label
Veliparib, Capecitabine, and T ...... Recurrent Neuroendocrine Tumor
@en
Veliparib, Capecitabine, and T ...... Recurrent Neuroendocrine Tumor
@nl
prefLabel
Veliparib, Capecitabine, and T ...... Recurrent Neuroendocrine Tumor
@en
Veliparib, Capecitabine, and T ...... Recurrent Neuroendocrine Tumor
@nl
P1050
P1050
P1476
A Phase 1 Study of Veliparib ( ...... entiated Neuroendocrine Tumors
@en
P3098
NCT02831179
P4844
P580
2017-12-01T00:00:00Z
P582
2019-02-01T00:00:00Z